Huai Guoli, Markmann James F, Deng Shaoping, Rickert Charles Gerard
Organ Transplantation Center Sichuan Provincial People's Hospital School of Medicine University of Electronic Science and Technology of China Chengdu China.
Center for Transplantation Sciences Massachusetts General Hospital Harvard Medical School Boston MA USA.
Clin Transl Immunology. 2021 Apr 2;10(4):e1270. doi: 10.1002/cti2.1270. eCollection 2021.
Regulatory B cells contribute to the regulation of immune responses in cancer, autoimmune disorders, allergic conditions and inflammatory diseases. Although most studies focus on regulatory B lymphocytes expressing interleukin-10, there is growing evidence that B cells producing transforming growth factor β (TGF-β) can also regulate T-cell immunity in inflammatory diseases and promote the emergence of regulatory T cells that contribute to the induction and maintenance of natural and induced immune tolerance. Most research on TGF-β regulatory B cells has been conducted in models of allergy, cancer and autoimmune diseases, but there has, as yet, been limited scrutiny of their role in the transplant setting. Herein, we review recent investigations seeking to understand how TGF-β-producing B cells direct the immune response in various inflammatory diseases and whether these regulatory cells may have a role in fostering tolerance in transplantation.
调节性B细胞有助于调节癌症、自身免疫性疾病、过敏性疾病和炎症性疾病中的免疫反应。尽管大多数研究集中在表达白细胞介素-10的调节性B淋巴细胞上,但越来越多的证据表明,产生转化生长因子β(TGF-β)的B细胞也可以调节炎症性疾病中的T细胞免疫,并促进调节性T细胞的出现,这些调节性T细胞有助于诱导和维持天然及诱导性免疫耐受。关于TGF-β调节性B细胞的大多数研究是在过敏、癌症和自身免疫性疾病模型中进行的,但迄今为止,对它们在移植环境中的作用的审查有限。在此,我们综述了最近的研究,旨在了解产生TGF-β的B细胞如何在各种炎症性疾病中指导免疫反应,以及这些调节性细胞是否可能在促进移植耐受中发挥作用。